Article
Increased Risk of Myositis-Specific and Myositis-Associated Autoantibodies after COVID-19 pandemic and Vaccination: A Spanish Multicenter Collaborative Study
2024-11-08
Abstract excerpt
Emerging evidence suggests that the severe-acute-respiratory-syndrome-related coronavirus (SARS- CoV-2) infection and anti-SARS-CoV-2 vaccines may trigger autoimmune responses in genetically predisposed individuals. Idiopathic inflammatory myopathies (IIMs) are a group of diseases with a broad spectrum of clinical manifestations featured by the presence of myositis autoantibodies (MAs). The diagnosis of IIM is cha...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- efdde201-bd88-5968-8215-77a8dd9442f5
- DOI
- 10.20944/preprints202411.0636.v1
